Skip to content

Barbara A. Konkle, MD

NPI 1972545796ActiveIndividual· Internal Medicine, Hematology· Seattle, WA

Internal Medicine, Hematology (MD) in Seattle, Washington, licensed in WA, with an NPI issued in June 2006. Part D covered 14 prescriptions written in 2024. Takeda Pharmaceuticals U.S.A., Inc. was the largest of 4 companies reporting payments in 2025, $32,914 in all, mostly consulting fees.

Overview

NPI1972545796
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 13, 2006
Last updated in NPPESJul 27, 2018

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology (WA)

Part D prescriptions in 2024

Prescriptions (claims)14 · 14 30-day fills
Total drug cost$2,630

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$32,914 · 12 payments from 4 companies
  • 2024$63,797 · 42 payments from 6 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$19,240 · 6 payments
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$12,820 · 2 payments
  • Travel and Lodging$775.77 · 3 payments
  • Food and Beverage$78.02 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology providers in Seattle

All Internal Medicine, Hematology providers in Washington →